港股異動丨遠大住工(2163.HK)漲5.43% 裝配式建築前景看好
格隆匯8月7日丨遠大住工(2163.HK)漲5.43%,報36.9港元,總市值180億港元。中信建投近期發佈研報稱,預計遠大住工(02163)2020-2022年歸母淨利潤分別為6.86/9.14/12.50億元,同比增長分別為1.3%/33.2%/36.8%,給予遠大住工“買入”評級,目標價40.30港元。此外,為推進建築工業化、數字化、智能化升級,加快建造方式轉變,推動建築業高質量發展,住建部等十三部門發佈關於推動智能建造與建築工業化協同發展的指導意見。在加快建築工業化升級方面,要求大力發展裝配式建築,推動建立以標準部品為基礎的專業化、規模化、信息化生產體系。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.